Each tablet contains:

active ingredients: Acetylsalicylic acid – 75 mg, Magnesium hydroxide – 15.2 mg;

For a full list of excipients, see section 6.1.

The tablets should be swallowed whole with water.

For primary prevention of cardiovascular diseases such as thrombosis and acute heart failure in the presence of risk factors (eg, diabetes, hyperlipidemia, hypertension, obesity, smoking, older age) appoint 2 tablets of Cardiolife containing acetylsalicylic acid at a dose of 75 mg the first day, followed by 1 tablet of Cardiolife 1 time / day.

For the prevention of repeated myocardial infarction and thrombosis of blood vessels appoint Cardiolife at a dose of 75-150 mg 1 time / day.

For the prevention of thromboembolic events after vascular surgery (coronary artery bypass grafting, percutaneous transluminal coronary angioplasty) appoint Cardiolife at a dose of 75-150 mg 1 time / day.

In unstable angina appoint Cardiolife at a dose of 75-150 mg 1 time / day.

ATC code: B01AC30.

Pharmacotherapeutic group: Antiagregant.

List of excipients

Tablet core:

Microcrystalline cellulose;

Sodium starch glycolate;

Magnesium stearate;

Tablet coating:

Titanium dioxide;

Hypromellose;

Talc purified;

Propylenglycol.

For more detailed information about the drug, click: http://pharm.cals.am/pharm/data/drug_134425/1736329537406.pdf